(Q80406288)
Statements
Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial (English)
Maha H A Hussain
Gary R MacVicar
Daniel P Petrylak
Rodney L Dunn
Ulka Vaishampayan
Primo N Lara
Gurkamal S Chatta
David M Nanus
L Michael Glode
Donald L Trump
Helen Chen
National Cancer Institute